Cargando…

A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study

BACKGROUND: Complete resection (CR) serves as the standard of surgical treatment for retroperitoneal liposarcoma (RPLS). Unfortunately, even at referral centers, recurrence rates are high, and CR may not address multifocal diseases, which are a common phenomenon in RPLS. We sought to retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Cheng-Li, Zhang, Ling-Ling, Tseng, William W., Qiu, Fa-Bo, Lu, Wei-Qi, Dai, You-Guo, Rao, Xiao-Song, Li, Wen-Jie, Zhang, Gao-Kui, Chen, Jun, Liu, Wen-Qing, Chen, Xiao-Bing, Xiao, Meng-Meng, Cha, Li-Chao, Wang, Jiong-Yuan, Ren, Yu-Bo, Yang, Hao-Yun, Luo, Cheng-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372660/
https://www.ncbi.nlm.nih.gov/pubmed/35965811
http://dx.doi.org/10.21037/atm-22-3332
_version_ 1784767435451138048
author Miao, Cheng-Li
Zhang, Ling-Ling
Tseng, William W.
Qiu, Fa-Bo
Lu, Wei-Qi
Dai, You-Guo
Rao, Xiao-Song
Li, Wen-Jie
Zhang, Gao-Kui
Chen, Jun
Liu, Wen-Qing
Chen, Xiao-Bing
Xiao, Meng-Meng
Cha, Li-Chao
Wang, Jiong-Yuan
Ren, Yu-Bo
Yang, Hao-Yun
Luo, Cheng-Hua
author_facet Miao, Cheng-Li
Zhang, Ling-Ling
Tseng, William W.
Qiu, Fa-Bo
Lu, Wei-Qi
Dai, You-Guo
Rao, Xiao-Song
Li, Wen-Jie
Zhang, Gao-Kui
Chen, Jun
Liu, Wen-Qing
Chen, Xiao-Bing
Xiao, Meng-Meng
Cha, Li-Chao
Wang, Jiong-Yuan
Ren, Yu-Bo
Yang, Hao-Yun
Luo, Cheng-Hua
author_sort Miao, Cheng-Li
collection PubMed
description BACKGROUND: Complete resection (CR) serves as the standard of surgical treatment for retroperitoneal liposarcoma (RPLS). Unfortunately, even at referral centers, recurrence rates are high, and CR may not address multifocal diseases, which are a common phenomenon in RPLS. We sought to retrospectively compare the clinical outcomes of RPLS patients treated with total (ipsilateral) retroperitoneal lipectomy (TRL) and CR. Because TRL remove potentially multifocal tumors in the fat, patients may have a better prognosis than CR. METHODS: Patients with primary/first-recurrent RPLS who had been treated at 5 referral centers were recruited from December 2014 to June 2018. Multivariable Cox regression analyses were conducted to determine the effects of demographic, operative, and clinicopathological variables on the following primary endpoints: local recurrence (LR), local recurrence-free survival (LRFS), and overall survival (OS). RESULTS: A total of 134 patients were enrolled in this retrospective study, 53 of whom underwent TRL, and 81 of whom underwent CR. The 2 groups were comparable in terms of age, gender, presentation (primary vs. first-recurrent RPLS), number of tumors (unifocal vs. multifocal) at presentation, and Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grade. The TRL group had higher levels of preoperative hemoglobin (Hb) (13 vs. 12.5 g/dL; P=0.008) and a lower amount of intraoperative blood loss (400 vs. 500 mL; P=0.034), but there were no significant differences in the length of hospital stay (23 vs. 22 d; P=0.47) or complications (32 vs. 30; P=0.82) between the 2 groups. In a subset of patients with multifocal tumors at initial presentation, OS was more prolonged in those treated with TRL than those treated with CR (P=0.0272). Based on the multivariable analysis, primary liposarcoma and a low FNCLCC grade were associated with decreased LR and improved OS. CONCLUSIONS: TRL is a safe procedure that positively affects the OS of patients with multifocal RPLS. This novel strategy deserves further investigation in prospective studies.
format Online
Article
Text
id pubmed-9372660
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-93726602022-08-13 A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study Miao, Cheng-Li Zhang, Ling-Ling Tseng, William W. Qiu, Fa-Bo Lu, Wei-Qi Dai, You-Guo Rao, Xiao-Song Li, Wen-Jie Zhang, Gao-Kui Chen, Jun Liu, Wen-Qing Chen, Xiao-Bing Xiao, Meng-Meng Cha, Li-Chao Wang, Jiong-Yuan Ren, Yu-Bo Yang, Hao-Yun Luo, Cheng-Hua Ann Transl Med Original Article BACKGROUND: Complete resection (CR) serves as the standard of surgical treatment for retroperitoneal liposarcoma (RPLS). Unfortunately, even at referral centers, recurrence rates are high, and CR may not address multifocal diseases, which are a common phenomenon in RPLS. We sought to retrospectively compare the clinical outcomes of RPLS patients treated with total (ipsilateral) retroperitoneal lipectomy (TRL) and CR. Because TRL remove potentially multifocal tumors in the fat, patients may have a better prognosis than CR. METHODS: Patients with primary/first-recurrent RPLS who had been treated at 5 referral centers were recruited from December 2014 to June 2018. Multivariable Cox regression analyses were conducted to determine the effects of demographic, operative, and clinicopathological variables on the following primary endpoints: local recurrence (LR), local recurrence-free survival (LRFS), and overall survival (OS). RESULTS: A total of 134 patients were enrolled in this retrospective study, 53 of whom underwent TRL, and 81 of whom underwent CR. The 2 groups were comparable in terms of age, gender, presentation (primary vs. first-recurrent RPLS), number of tumors (unifocal vs. multifocal) at presentation, and Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC) grade. The TRL group had higher levels of preoperative hemoglobin (Hb) (13 vs. 12.5 g/dL; P=0.008) and a lower amount of intraoperative blood loss (400 vs. 500 mL; P=0.034), but there were no significant differences in the length of hospital stay (23 vs. 22 d; P=0.47) or complications (32 vs. 30; P=0.82) between the 2 groups. In a subset of patients with multifocal tumors at initial presentation, OS was more prolonged in those treated with TRL than those treated with CR (P=0.0272). Based on the multivariable analysis, primary liposarcoma and a low FNCLCC grade were associated with decreased LR and improved OS. CONCLUSIONS: TRL is a safe procedure that positively affects the OS of patients with multifocal RPLS. This novel strategy deserves further investigation in prospective studies. AME Publishing Company 2022-07 /pmc/articles/PMC9372660/ /pubmed/35965811 http://dx.doi.org/10.21037/atm-22-3332 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Miao, Cheng-Li
Zhang, Ling-Ling
Tseng, William W.
Qiu, Fa-Bo
Lu, Wei-Qi
Dai, You-Guo
Rao, Xiao-Song
Li, Wen-Jie
Zhang, Gao-Kui
Chen, Jun
Liu, Wen-Qing
Chen, Xiao-Bing
Xiao, Meng-Meng
Cha, Li-Chao
Wang, Jiong-Yuan
Ren, Yu-Bo
Yang, Hao-Yun
Luo, Cheng-Hua
A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study
title A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study
title_full A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study
title_fullStr A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study
title_full_unstemmed A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study
title_short A better overall survival (OS) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study
title_sort better overall survival (os) for total (ipsilateral) retroperitoneal lipectomy than standard complete resection in patients with retroperitoneal liposarcoma: a comparative multi-institutional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372660/
https://www.ncbi.nlm.nih.gov/pubmed/35965811
http://dx.doi.org/10.21037/atm-22-3332
work_keys_str_mv AT miaochengli abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT zhanglingling abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT tsengwilliamw abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT qiufabo abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT luweiqi abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT daiyouguo abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT raoxiaosong abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT liwenjie abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT zhanggaokui abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT chenjun abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT liuwenqing abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT chenxiaobing abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT xiaomengmeng abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT chalichao abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT wangjiongyuan abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT renyubo abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT yanghaoyun abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT luochenghua abetteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT miaochengli betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT zhanglingling betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT tsengwilliamw betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT qiufabo betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT luweiqi betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT daiyouguo betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT raoxiaosong betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT liwenjie betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT zhanggaokui betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT chenjun betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT liuwenqing betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT chenxiaobing betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT xiaomengmeng betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT chalichao betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT wangjiongyuan betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT renyubo betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT yanghaoyun betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy
AT luochenghua betteroverallsurvivalosfortotalipsilateralretroperitoneallipectomythanstandardcompleteresectioninpatientswithretroperitonealliposarcomaacomparativemultiinstitutionalstudy